Aspire Biopharma Holdings (ASBP) Shares Outstanding (2022 - 2026)

Aspire Biopharma Holdings (ASBP) has 5 years of Shares Outstanding (Entity) data on file, last reported at $167470.0 in Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 430.39% year-over-year to $167470.0 in Q1 2026; TTM through Mar 2026 was $167470.0, a 430.39% increase from a year earlier, with the FY2025 full-year figure at $49832.0, up 116.65% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $167470.0, up from $49832.0 in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for ASBP reached as high as $167470.0 in Q1 2026 and fell as low as $20115.0 in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $34033.7 across 5 years, with a median of $20115.0 in 2022.
• Across the five-year window, Shares Outstanding (Entity) changed 0.0% in 2023 and surged 430.39% in 2026, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $20115.0 in 2022, then changed by 0.0% to $20115.0 in 2023, then climbed by 14.35% to $23001.0 in 2024, then soared by 116.65% to $49832.0 in 2025, then jumped by 236.07% to $167470.0 in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $167470.0 in Q1 2026, $49832.0 in Q4 2025, and $41272.0 in Q3 2025.